III.2 Saline infusion sonography (SIS) or office hysteroscopy: Which one is the best? A prospective randomised study

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Timmerman, D ^c   Deprest, J ^c   Bourne, T ^a   Van Berghe, I Den ^c   Collins, W P ^b   Vergote, I ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; BREAST CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTEROSCOPY; MAJOR CLINICAL STUDY; PATIENT MONITORING; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

EID: 0031716387     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00099-9     Document Type: Conference Paper

References (10)

1. Assikis VJ, Neven P, Jordan VC, Vergote I. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 1996, 32A, 1464-1476.
2. Neven P, De Muylder X, Van Belle Y, Vanderick G, De Muylder E. Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol 1990, 35, 235-238.
3. Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 1993, 81, 660-664.
4. Kedar RP, Bourne TH, Powles TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 1994, 343, 1318-1321.
5. Timmerman D, Deprest J, Vergote I. Tamoxifen-induced endometrial polyp [reply]. N Engl J Med 1996, 335, 1650.
6. Cohen I, Altaras MM, Shapira J, Tepper R, Beyth Y. Postmenopausal tamoxifen treatment and endometrial pathology. Obstet Gynecol Survey 1994, 49, 823-829.
7. Goldstein S. Unusual ultrasonographic appearance of uterus in postmenopausal patients receiving tamoxifen [reply]. Am J Obstet Gynecol 1995, 172, 717-718.
8. Achiron R, Grisaru D, Golan-Porat N, Lipitz S. Tamoxifen and the uterus: an old drug tested by new modalities. Ultrasound Obstet Gynecol 1996, 7, 374-378.
9. Timmerman D, Deprest J, Bourne TH, Van den Berghe I, Collins WP, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in tamoxifen-treated postmenopausal breast cancer patients. Am J Obstet Gynecol (in press).
10. Widrich T, Bradley LD, Mitchinson AR, Collins RL. Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. Am J Obstet Gynecol 1996, 174, 1327-1334.